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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To determine the effectiveness and safety of exercise-based rehabilitation on the mortality, hospital admissions, morbidity, exercise ca-
pacity, health-related quality of life, and return to work of people after heart transplantation.
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B A C K G R O U N D
Description of the condition
Despite modern advances in medical treatment, heart transplanta-
tion is considered to be the gold standard treatment modality for
selected people with end-stage heart failure (Yancy 2013). In gen-
eral, people with advanced heart failure should be considered for
heart transplantation if optimal medical therapy as recommended
by the American College of Cardiology/American Heart Association
(ACC/AHA) guidelines and cardiac resynchronisation therapy have
failed to improve symptoms or halt progression of the underlying
pathology (Shah 2012; Yancy 2013). About 3800 heart transplants
are currently performed annually worldwide (ISHLT 2015). The vast
majority of these are performed in the United States (2000 to 2300
annually). In 2013 in the United States over 50% of heart transplants
were performed in people with cardiomyopathy, about a third in
people with coronary heart disease, and 10% in people with con-
genital heart disease (Colvin-Adams 2015).
Since the first heart transplantation over 45 years ago, there has
been significant progress in the field. Survival and quality of life are
now generally considered to be excellent, with many heart trans-
plant recipients now being able to return to work (Hollenberg 2004;
Lund 2013). Since the 1970s, the one-year post-transplantation sur-
vival rates have improved from 30% to almost 90% (Colvin-Adams
2015; Stehlik 2012), while three- and five-year survival are now ap-
proximately 80% and 75%, respectively (Colvin-Adams 2015).
While advances in transplant candidate selection, surgical tech-
niques, immunosuppressive modalities, and postoperative care
have led to improved long-term outcomes after transplantation
(Butler 2004; Lietz 2007), long-term survival remains limited, and
exercise capacity and health-related quality of life of heart trans-
plant recipients remain inferior to that of age-matched healthy in-
dividuals. Preoperatively, most heart transplant candidates have
chronic debilitating cardiac illness, with concomitant poor exercise
capacity and cardiac cachexia. Post-transplantation, exercise ca-
pacity remains diminished due to decreased chronotropic compe-
tence associated with cardiac allograft denervation (Bengel 2001;
Kao 1994; Kao 1995), diastolic dysfunction (Kao 1994; Kao 1995;
Paulus 1992), impaired peripheral vascular function (Haykowsky
2005; Jendzjowsky 2007), as well as changes in skeletal muscle
strength and biochemistry due to post-transplant deconditioning
or treatment with high-dose immunosuppressive therapy (Braith
2000; Lampert 1996). Although maximum exercise capacity in-
creases on average from 40% to 50% of normal values immediate-
ly after transplant, to 60% at two years' post-transplant (Douard
1997; Kobashigawa 1999b; Mandak 1995), maximum exercise ca-
pacity decreases thereafter at a mean rate of approximately 5% per
year (Douard 1997; Mandak 1995), compared with a rate of only
1.5% each year in healthy individuals (Jackson 1996).
Recent data from the United States show that 36% of heart re-
cipients are hospitalised during the first year post-transplantation,
and 61% are hospitalised within four years (Colvin-Adams 2014;
Colvin-Adams 2015). The most common reasons for hospitalisation
are transplant complications and infections. Acute rejection, which
used to be one of the main causes of mortality in transplant recip-
ients, now has relatively low incidence due to modern drug ther-
apies, although post-transplant acute rejection still occurs in 24%
of heart recipients in the first year post-transplantation and 45% of
heart recipients within five years. The most common causes of ear-
ly mortality during the first three months after transplant are infec-
tion, cardiovascular and cerebrovascular events, and graF failure
(Colvin-Adams 2015). In the long term, mortality is most often the
result of cardiovascular and cerebrovascular events, with coronary
allograft vasculopathy being the main cause of death in heart trans-
plant recipients after five years (Taylor 2007; Tjang 2008).
New challenges to heart transplantation have recently arisen. In the
last decade, antibody-mediated rejection has been recognised as
a particularly challenging form of rejection in heart transplant re-
cipients, which is a major cause of allograft failure and is associat-
ed with a greater risk of coronary allograft vasculopathy and death
(Colvin 2015; Nair 2011). The demographics of heart transplant re-
cipients are also changing, with a greater number of more compli-
cated, older recipients in their 60s and 70s, who tend to have higher
risks of infection, coronary allograft vasculopathy, and malignancy,
which compromise their long-term survival (Kobashigawa 2012). In
the United States, the proportion of candidates for heart transplan-
tation aged 65 years or older increased from 13% in 2002 to 20%
in 2012 (Colvin-Adams 2014). Advances in heart surgery have also
led to a greater proportion of younger people with congenital heart
disease who are surviving past childhood and later develop heart
failure. These patients can have complex cardiopulmonary anato-
my and have commonly received multiple median sternotomies,
which increase the risk of postoperative bleeding and mortality
(Tonsho 2014). The candidacy for heart transplant has also been al-
tered in recent years by the increase in the management of candi-
dates with mechanical ventricular assist devices prior to transplan-
tation, with almost 40% of all adult heart transplant recipients now
bridged to transplant with a durable device (Stehlik 2014).
Description of the intervention
Based on current evidence, national and international guidelines
on the management of coronary heart disease and heart failure
including those by the ACC/AHA, European Society of Cardiology,
and National Institute for Health and Care Excellence in the Unit-
ed Kingdom, consistently recommend cardiac rehabilitation (CR)
as an effective and safe intervention (McMurray 2012; NICE 2013;
Yancy 2013). Many definitions of CR have been proposed, but the
following definition encompasses the key concepts of CR: “The co-
ordinated sum of activities required to influence favourably the un-
derlying cause of cardiovascular disease, as well as to provide the
best possible physical, mental and social conditions, so that the pa-
tients may, by their own efforts, preserve or resume optimal func-
tioning in their community and through improved health behav-
iour, slow or reverse progression of disease” (BACPR 2012). Car-
diac rehabilitation is a complex intervention that may involve a va-
riety of therapies, including exercise, risk factor management and
lifestyle education, behaviour change, psychological support, and
strategies that are aimed at targeting traditional risk factors for car-
diovascular disease, that is ‘comprehensive CR’ (Corra 2005). The
patient groups routinely recommended for CR include people with
post-myocardial infarction, postrevascularisation and/or valvular
procedure and heart failure heart surgery (that is bypass surgery or
valvular surgery, or both). CR programmes have traditionally been
offered in a supervised, centre-based setting. However, many peo-
ple do not receive rehabilitation (Bethell 2008), and with uptake
of CR for both coronary heart disease and heart failure currently
at suboptimal levels (Dalal 2012; NICE 2013; Tierney 2011), home-
based CR programmes are increasingly being introduced to widen
access and participation.
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How the intervention might work
Recent Cochrane reviews of exercise-based CR in coronary heart
disease and heart failure populations have shown CR to be a safe
and effective intervention in reducing the risk of hospital admis-
sions and conferring important improvements in health-related
quality of life in these patient groups (Anderson 2016; Taylor 2014).
For decades, exercise restrictions were applied to heart trans-
plant recipients, as it was believed that the transplanted heart
remained denervated, with a higher resting heart rate and a re-
duced heart rate response (chronotropic incompetence). Howev-
er, there is now ample evidence that both endurance and resis-
tance training are well tolerated in heart transplant recipients, and
it is widely believed that reinnervation and autonomic nervous con-
trol can be improved by physical training (Bernardi 2007), although
it is unclear whether time alone may result in the normalisation
of chronotropic responses, or whether this occurs in combination
with exercise and/or other factors (Nytroen 2013).
There is evidence from small, non-randomised studies that aerobic
exercise training is an effective intervention to reverse the patho-
physiological consequences associated with cardiac denervation
and prevent immunosuppression-induced adverse effects (Braith
2005; Braith 2008; Haykowsky 2005; Keteyian 1991; Kobashigawa
1999a; Marconi 2003). In an assessment of the time course of phys-
ical reconditioning and skeletal muscle adaptation by exercise
training in people five years' post-transplantation, a persistent im-
provement in exercise capacity was reported, indicating that ex-
ercise training could counteract the negative side effects of im-
munosuppressive treatment on skeletal muscles (Tegtbur 2005). In
a more recent randomised controlled trial (RCT), supervised exer-
cise training was reported to improve peak oxygen uptake in clini-
cally stable heart recipients. This improvement was thought to be
as a function of favourable skeletal muscle adaptations that result
in increased oxygen utilisation by the active muscles (Haykowsky
2009). Furthermore, results from several randomised trials suggest
that high-intensity interval training is safe in heart transplant recip-
ients (Haykowsky 2009; Hermann 2011; Nytroen 2012), and leads
to superior improvements in peak oxygen uptake compared with
moderate exercise (Dall 2014).
Large epidemiological studies have demonstrated the existence of
an inverse and independent association between exercise capacity
and mortality in apparently healthy participants (Kokkinos 2008),
older men (Kokkinos 2010b), and people with documented cardio-
vascular disease (Kokkinos 2008; Myers 2002). Indeed, a 1.0 meta-
bolic equivalent (MET; 1 MET = 3.5 ml/kg/min) increase in exercise
capacity has been shown to translate into a 12% improvement in
survival in individuals with existing cardiovascular disease (Kokki-
nos 2010a). However, uncertainty remains regarding the precise
role that exercise may play in reversing the abnormal cardiovascu-
lar and skeletal muscle function that remains after heart transplan-
tation, and whether such an exercise-based intervention has an ef-
fect on long-term survival of transplant recipients.
Why it is important to do this review
A 2010 position paper from the Cardiac Rehabilitation Section of
the European Association of Cardiovascular Prevention and Re-
habilitation, in reference to post-cardiac transplantation, stated:
“Early training programme can be beneficial in the early post-oper-
ative period as well as in the long-term. Although exercise training
would theoretically delay or prevent CAD progression in the trans-
planted heart, this still has to be studied” (Piepoli 2010). Nonethe-
less, despite this apparent lack of evidence, clinical practice guide-
lines recommend exercise training as standard care for heart trans-
plant recipients. The 2010 guidelines from the International Society
of Heart and Lung Transplantation for the care of heart transplant
recipients gave a Class 1 recommendation for the routine use of CR
with aerobic exercise training and resistance exercise after heart
transplantation. This was based on a level B rating of the evidence
(that is RCT), although “there is currently no information on poten-
tial long-term benefits” (Costanzo 2010).
A recent systematic review and meta-analysis identified 9 RCTs of
exercise training in 250 participants, 1 month to 7 years following
heart, lung, kidney, or liver transplantation (Didsbury 2013). This re-
view concluded that “exercise training is a promising but unproven
intervention for improving cardiovascular outcomes of solid organ
transplant recipients”. Studies of exercise in cardiac transplant re-
cipients have generally been performed early after transplantation
using moderate exercise training (Bernardi 2007; Karapolat 2008;
Kobashigawa 1999a). While several of these studies have report-
ed that aerobic exercise leads to improved exercise capacity af-
ter heart transplantation, the results are not entirely consistent,
and little is known about the type, frequency, or intensity of exer-
cise that provides the greatest health benefits in this population.
Moreover, little is known about the impact of exercise-based CR on
health-related quality of life or long-term mortality and morbidity
(Hsieh 2011).
Our scoping searches have identified additional RCTs that have
been published since the June 2012 cutoff of the systematic review
by Didsbury and colleagues.
O B J E C T I V E S
To determine the effectiveness and safety of exercise-based reha-
bilitation on the mortality, hospital admissions, morbidity, exercise
capacity, health-related quality of life, and return to work of people
after heart transplantation.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include RCTs of either a parallel-group or cross-over design.
Types of participants
We will include adults aged 18 years or older who have received a
heart transplant.
Where we identify studies that meet all of our inclusion criteria but
include a mixed population of participants, we will make every ef-
fort to obtain outcome data for the subset of relevant participants,
by contacting the authors. If this approach is not viable, then we
will include the data from the study in the meta-analysis if the sub-
set of relevant participants comprises 50% or more of the total in-
cluded participants, and we will perform a sensitivity analysis with
and without data from this study.
If considerable heterogeneity of the severity of participants is de-
tected amongst the included studies, then outcome data will be
stratified accordingly.
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Types of interventions
Exercise-based interventions either alone or where exercise train-
ing is a component of comprehensive CR (defined as programmes
including such components as health education and psychological
interventions in addition to exercise interventions). For the purpos-
es of this review, exercise includes any structured or taught pro-
grammes with the aim of improving functional ability and quality
of life.
The comparator group could include standard medical care, such
as drug therapy, and may have received (i) no exercise training; (ii)
a different dose of exercise training (for example low- versus high-
intensity exercise training); or (iii) an active intervention (that is ed-
ucation, psychological intervention).
Types of outcome measures
Primary outcomes• Cardiovascular mortality• Hospital admissions (all-cause and cardiovascular related)• Reported adverse events (including those related to (i) exercise
and (ii) transplantation treatments or drugs)
Secondary outcomes• All-cause mortality• Non-cardiovascular mortality (including chronic allograft vas-
culopathy, acute rejection, malignancy, and infection)• Return to work (including return to either full- or part-time em-
ployment, to the same or a reduced role, and to either the pre-
vious job or any new employment)• Exercise capacity assessed by validated outcome measure (e.g.
VO2 peak, 6-minute walk test)• Health-related quality of life assessed using validated instru-
ments (e.g. 36-Item Short Form Health Survey (SF-36), EQ-5D)• Costs• Adherence to exercise programme
Reporting of outcomes is not an inclusion or exclusion criterion for
the review.
Search methods for identification of studies
Electronic searches
We will search:
• Cochrane Central Register of Controlled Trials (CENTRAL) in the
Cochrane Library;• Database of Abstracts of Reviews of Effects (DARE);• Health Technology Assessment (HTA);• MEDLINE & MEDLINE In-Process (OVID);• EMBASE (OVID);• CINAHL Plus (EBSCO);• Conference Proceedings Citation Index - Science (CPCI-S) on
Web of Science Core Collection (Thomson Reuters).
We will design the search strategies with reference to those of the
previous related systematic reviews of exercise-based cardiac re-
habilitation (Heran 2011). We will search databases using a strategy
combining selected MeSH terms and free-text terms relating to ex-
ercise-based rehabilitation and heart transplantation, with filters
applied to limit to RCTs. We will use the Cochrane sensitivity-max-
imising RCT filter for MEDLINE, and will apply terms recommended
in the Cochrane Handbook for Systematic Reviews of Interventions
for EMBASE (Lefebvre 2011). We will apply adaptations of this fil-
ter to CINAHL and Web of Science. We will translate the MEDLINE
search strategy for use with the other databases using the appro-
priate controlled vocabulary as applicable. We will apply no date
limits. We will impose no language or other limitations and will give
consideration to variations in terms used and spellings of terms in
different countries so that the search strategy will not miss studies
because of such variations. See Appendix 1 for details of the search
strategies.
Searching other resources
We will handsearch reference lists of retrieved articles and system-
atic reviews for any studies not identified by the electronic search-
es. We will also search trial registers (World Health Organization
International Clinical Trials Registry Platform (WHO ICTRP; http://
www.who.int/ictrp/en) and ClinicalTrials.gov (https://clinicaltrial-
s.gov)) for ongoing clinical trials and will seek expert advice.
Data collection and analysis
Selection of studies
Two review authors (TN and LA) will independently screen titles and
abstracts of all the studies we identify as a result of the search for
inclusion and code them as 'retrieve' (eligible or potentially eligi-
ble/unclear) or 'do not retrieve'. In case of disagreement, a third re-
view author will be asked to arbitrate (RST). We will retrieve the full-
text study reports/publication, and two review authors (TN and LA)
will independently screen the full text and identify studies for inclu-
sion, and identify and record reasons for exclusion of the ineligible
studies. Any disagreements will be resolved through discussion or,
if required, by consulting a third person (RST). We will identify and
exclude duplicates and collate multiple reports of the same study
so that each study rather than each report is the unit of interest in
the review. We will record the selection process in sufficient detail
to complete a PRISMA flow diagram and 'Characteristics of exclud-
ed studies' table.
Data extraction and management
We will use a data collection form that has been piloted on at least
one study in the review to extract study characteristics and out-
come data. One review author (TN) will extract study characteris-
tics from included studies, and a second review author (LA) will
check against the trial report for accuracy. We will extract the fol-
lowing study characteristics.
1. Methods: study design, total duration of study, details of any
'run in' period, number of study centres and location, study set-
ting, withdrawals, and date of study.
2. Participants: N, mean age, age range, gender, time since trans-
plant, inclusion criteria, and exclusion criteria.
3. Interventions: intervention (including mode of exercise, dura-
tion, frequency, and intensity), description of usual care, and
length of follow-up
4. Outcomes: primary and secondary outcomes specified and col-
lected, and time points reported.
5. Notes: funding for trial and notable conflicts of interest of trial
authors.
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Two review authors (TN and LA) will independently extract out-
come data from included studies. Any disagreements will be re-
solved by consensus or by involving a third person (RST). One re-
view author (TN) will transfer data into the Review Manager file
(RevMan 2014). We will double-check that data is entered correct-
ly by comparing the data presented in the systematic review with
the study reports. A second review author (LA) will spot-check study
characteristics for accuracy against the trial report. If we find multi-
ple reports of the same study, we will assess the duplicate publica-
tions for additional data. We will contact study authors where nec-
essary to provide additional information.
Assessment of risk of bias in included studies
Two review authors (TN and LA) will independently assess risk of
bias for each study using the criteria outlined in the Cochrane Hand-
book for Systematic Reviews of Interventions (Higgins 2011). We will
assess the risk of bias according to the following domains.
1. Random sequence generation.
2. Allocation concealment.
3. Blinding of participants and personnel.
4. Incomplete outcome data.
5. Selective outcome reporting.
6. Other (specifically sources of funding).
We will also assess two further quality criteria: whether the study
groups were balanced at baseline, and if the study groups received
comparable care (apart from the exercise component of the inter-
vention). These criteria, agreed upon in advance by the review au-
thors, have not been validated but have been used to assess quality
in previous CR reviews (Anderson 2016; Brown 2011; Sibilitz 2016;
Taylor 2014; Taylor 2015). We will assess these two further quality
criteria as follows.
Groups balanced at baseline• Low risk of bias: The characteristics of the participants in the
intervention and control groups at baseline are reported to be
comparable or can be judged to be comparable (e.g. baseline
data reported in Table 1) in terms of likely main prognostic fac-
tors.• Unclear risk of bias: Whether the characteristics of the partic-
ipants in the intervention and control groups are balanced at
baseline is not reported, and reported information is inadequate
to assess this (e.g. no Table 1).• High risk of bias: There is evidence of substantive imbalance
in the baseline characteristics of the intervention and control
groups with regard to likely major prognostic factors.
Groups received comparable treatment (except exercise)• Low risk of bias: All co-interventions were delivered equally
across intervention and control groups.• Unclear risk of bias: Information to assess whether co-interven-
tions were delivered equally across groups was insufficient.• High risk of bias: The co-interventions were not delivered equally
across intervention and control groups.
A second review author (LA) will check all 'Risk of bias' assessments,
and any discrepancies will be resolved by consensus. We will grade
each potential source of bias as high, low, or unclear and provide
a quote from the study report together with a justification for our
judgement in the 'Risk of bias' table. We will summarise the 'Risk of
bias' judgements across different studies for each of the domains
listed. Where information on risk of bias relates to unpublished da-
ta or correspondence with a trialist, we will note this in the 'Risk of
bias' table.
When considering treatment effects, we will take into account the
risk of bias for the studies that contribute to that outcome.
Assessment of bias in conducting the systematic review
We will conduct the review according to this published protocol
and report any deviations from it in the 'Differences between pro-
tocol and review' section of the systematic review.
Unit of analysis issues
In accordance with Section 16.4 of the Cochrane Handbook for Sys-
tematic Reviews of Intervention (Higgins 2011), we will aim to in-
clude data from both periods of any cross-over trials identified,
assuming (i) there has been a wash-out period considered long
enough to reduce carry-over, (ii) no irreversible events such as mor-
tality have occurred, and (iii) appropriate statistical approaches
have been used.
Dealing with missing data
We will contact investigators or study sponsors to verify key study
characteristics and obtain missing numerical outcome data where
possible (for example when a study is identified as abstract only).
Where this is not possible, and the missing data are thought to in-
troduce serious bias, we will explore the impact of including such
studies on the overall assessment of results by a sensitivity analy-
sis.
Assessment of heterogeneity
We will explore heterogeneity amongst included studies qualita-
tively (by comparing the characteristics of included studies) and
quantitatively (using the Chi2 test of heterogeneity and I2 statistic).
We will use a threshold of I2 greater than 50% for both dichotomous
and continuous outcomes to determine the statistical model to be
used for meta-analysis.
Assessment of reporting biases
If more than 10 trials can be pooled, we will create and examine a
funnel plot to explore possible small-study biases for the primary
outcomes.
Data synthesis
Dichotomous outcomes for each comparison will be expressed as
risk ratios with 95% confidence intervals. Continuous data will be
expressed as mean difference with 95% confidence intervals, or,
where an outcome is measured and reported in more than one way,
as standardised mean difference with 95% confidence intervals. We
will enter data presented as a scale with a consistent direction of
effect. If there is a statistically significant absolute risk difference,
we will calculate the associated number needed to treat to bene-
fit/harm.
Where appropriate, we will pool data from each study using a fixed-
effect model, except where substantial heterogeneity exists. If pos-
sible, we will pool the results for health-related quality of life us-
ing a standardised mean difference. If there is substantial statistical
Exercise-based cardiac rehabilitation in heart transplant recipients (Protocol)
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heterogeneity (P value less than 0.10, I2 greater than 50%) associ-
ated with an effect estimate, we will apply a random-effects model,
which provides a more conservative statistical comparison of the
difference between intervention and control because a confidence
interval around the effect estimate is wider than a confidence inter-
val around a fixed-effect estimate. If a statistically significant differ-
ence is still present using the random-effects model, we will also re-
port the fixed-effect pooled estimate and 95% confidence interval
because of the tendency of smaller trials, which are more suscepti-
ble to publication bias, to be overweighted with a random-effects
analysis (Heran 2008a; Heran 2008b).
We will use the funnel plot and the Egger test to examine small-
study bias (Egger 1997). We will process data in accordance with the
Cochrane Handbook for Systematic Reviews of Interventions (Hig-
gins 2011). We will complete data synthesis and analyses using Re-
view Manager 5.3 software and Stata version 13.0 (RevMan 2014;
StataCorp 2013).
Summary of findings table
We will employ the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) approach to interpret re-
sult findings and use GRADEpro GDT 2015 to import data from
Review Manager to create 'Summary of findings' tables. We will
create a 'Summary of findings' table using the following out-
comes: all-cause mortality, cardiovascular mortality, non-cardio-
vascular mortality (including chronic allograft vasculopathy, acute
rejection, malignancy, and infection), hospital admissions, adverse
events, exercise capacity, and return to work. We will use the five
GRADE considerations (study limitations, consistency of effect, im-
precision, indirectness, and publication bias) to assess the quali-
ty of a body of evidence as it relates to the studies that contribute
data to the meta-analyses for the prespecified outcomes. We will
use methods and recommendations described in Section 8.5 and
Chapter 12 of the Cochrane Handbook for Systematic Reviews of In-
terventions using GRADEpro software (Higgins 2011). We will justify
all decisions to down- or up-grade the quality of studies using foot-
notes, and we will make comments to aid readers' understanding
of the review where necessary.
Subgroup analysis and investigation of heterogeneity
As we anticipate length of follow-up to be a driver of intervention ef-
fect, we will seek to stratify meta-analysis of each outcome accord-
ing to the length of trial duration, that is 'short-term' follow-up (6 to
12 months), 'medium-term' follow-up (13 to 36 months), and 'long-
term' follow-up (more than 36 months). We will also aim to un-
dertake univariate meta-regression to explore heterogeneity and
examine potential treatment effect modifiers. We will seek to test
eight a priori hypotheses that there may be differences in the effect
of exercise-based CR on total mortality, cardiovascular mortality,
and hospitalisations and exercise capacity across particular sub-
groups:
1. type of CR (exercise-only CR versus comprehensive CR);
2. 'dose' of exercise intervention [dose = number of weeks of exer-
cise training x average number of sessions/week x average dura-
tion of session in minutes] (dose ≥ 1000 units versus dose < 1000
units);
3. follow-up period;
4. year of publication;
5. sample size;
6. setting (home- or centre-based CR);
7. study location (continent).
Given the anticipated small ratio of trials to covariates, meta-re-
gression will be limited to univariate analysis (Higgins 2011). How-
ever, given the anticipated small number of included studies, it is
unlikely that we will be able to use stratified meta-analysis or meta-
regression methods.
We will extract results of subgroup analyses, including partici-
pant-level subgroup analyses, if reported by individual included
studies, for example if a trial reported whether there was a differ-
ence in the effectiveness of CR between males and females.
Reaching conclusions
We will base our conclusions only on findings from the quantitative
or narrative synthesis of included studies for this review. We will
avoid making recommendations for practice, and our implications
for research will suggest priorities for future research and outline
what the remaining uncertainties are in the area.
Sensitivity analysis
Where there is any doubt as to whether the findings of the meta-
analysis are robust to the inclusion of any data, we will conduct a
sensitivity analysis. For example, a sensitivity analysis may be con-
ducted to test the robustness of the anlaysis to the inclusion of
studies of high versus low risk of bias, or where there is missing da-
ta. We will report results of both analyses in a summary table.
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A P P E N D I C E S
Appendix 1. Preliminary MEDLINE (Ovid) search strategy
Preliminary search strategy
Cochrane Library
#1 MeSH descriptor: [Exercise Therapy] explode all trees
#2 MeSH descriptor: [Sports] explode all trees
#3 MeSH descriptor: [Physical Exertion] explode all trees
#4 rehabilitat*
#5 (physical* near (fit* or train* or therap* or activit*))
#6 MeSH descriptor: [Exercise] explode all trees
#7 (train*) near (strength* or aerobic* or exercise*)
#8 ((exercise* or fitness) near/3 (treatment or intervent* or program*))
#9 MeSH descriptor: [Rehabilitation] explode all trees
#10 kinesiotherap*
#11 MeSH descriptor: [Physical Education and Training] explode all trees
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#12 (run* or walk* or jog* or danc*)
#13 ((lifestyle or life-style) near/5 (interven* or program* or treatment*))
#14 MeSH descriptor: [Dance Therapy] this term only
#15 MeSH descriptor: [Patient Education as Topic] this term only
#16 (patient* near/5 educat*)
#17 ((lifestyle or life-style) near/5 (interven* or program* or treatment*))
#18 MeSH descriptor: [Self Care] this term only
#19 (self near/5 (manag* or care or motivate*))
#20 MeSH descriptor: [Psychotherapy] explode all trees
#21 psychotherap*
#22 (psycholog* near/5 intervent*)
#23 MeSH descriptor: [Counseling] this term only
#24 (counselling or counseling)
#25 ((behavior* or behaviour*) near/5 (modify or modificat* or therap* or change))
#26 (psycho-educat* or psychoeducat*)
#27 (motivat* near/5 (intervention or interv*))
#28 MeSH descriptor: [Health Education] this term only
#29 (health near/5 educat*)
#30 (psychosocial or psycho-social)
#31 (cognitive near/2 behav*)
#32 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or
#25 or #26 or #27 or #28 or #29 or #30 or #31
#33 MeSH descriptor: [Heart Transplantation] explode all trees
#34 (heart near/2 transplant*)
#35 (cardiac near/2 transplant*)
#36 heart next graF*
#37 #33 or #34 or #35 or #36
#38 #32 and #37
MEDLINE OVID
1. exp Exercise Therapy/
2. Sports/
3. Physical Exertion/
4. rehabilitat*.mp.
5. (physical* adj5 (fit* or train* or therap* or activit*)).mp.
6. exp Exercise/
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7. (train* adj5 (strength* or aerobic* or exercise*)).tw.
8. ((exercise* or fitness) adj3 (treatment or intervent* or program*)).tw.
9. exp Rehabilitation/
10. kinesiotherap*.tw.
11. "Physical Education and Training"/
12. (run* or walk* or jog* or danc*).tw.
13. (("lifestyle" or life-style) adj5 (physical* or activ*)).tw.
14. Dance Therapy/
15. Patient Education as Topic/
16. (patient* adj5 educat*).tw.
17. ((lifestyle or life-style) adj5 (interven* or program* or treatment*)).tw.
18. Self Care/
19. (self adj5 (manag* or care or motivate*)).tw.
20. exp Psychotherapy/
21. psychotherap*.tw.
22. (psycholog* adj5 intervent*).tw.
23. Counseling/
24. (counselling or counseling).tw.
25. ((behavior* or behaviour*) adj5 (modify or modificat* or therap* or change)).tw.
26. (psycho-educat* or psychoeducat*).tw.
27. (motivat* adj5 (intervention or interv*)).tw.
28. Health Education/
29. (health adj5 educat*).tw.
30. (psychosocial or psycho-social).tw.
31. (cognitive adj2 behav*).tw.
32. or/1-31
33. exp Heart Transplantation/
34. (heart adj2 transplant*).tw.
35. (cardiac adj2 transplant*).tw.
36. heart graF*.tw.
37. or/33-36
38. 32 and 37
39. randomized controlled trial.pt.
40. controlled clinical trial.pt.
41. randomized.ab.
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42. placebo.ab.
43. drug therapy.fs.
44. randomly.ab.
45. trial.ab.
46. groups.ab.
47. 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46
48. exp animals/ not humans.sh.
49. 47 not 48
50. 38 and 49
EMBASE OVID
1. exp kinesiotherapy/
2. exp sport/
3. exp exercise/
4. rehabilitat*.tw.
5. (physical* adj5 (fit* or train* or therap* or activit*)).tw.
6. (train* adj5 (strength* or aerobic* or exercise*)).tw.
7. ((exercise* or fitness) adj3 (treatment or intervent* or program*)).tw.
8. exp rehabilitation/
9. kinesiotherap*.tw.
10. (run* or walk* or jog* or danc*).tw.
11. (("lifestyle" or life-style) adj5 (physical* or activ*)).tw.
12. dance therapy/
13. patient education/
14. (patient* adj5 educat*).tw.
15. ((lifestyle or life-style) adj5 (interven* or program* or treatment*)).tw.
16. self care/
17. (self adj5 (manag* or care or motivate*)).tw.
18. exp psychotherapy/
19. psychotherap*.tw.
20. (psycholog* adj5 intervent*).tw.
21. counseling/
22. (counselling or counseling).tw.
23. ((behavior* or behaviour*) adj5 (modify or modificat* or therap* or change)).tw.
24. (psycho-educat* or psychoeducat*).tw.
25. (motivat* adj5 (intervention or interv*)).tw.
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26. health education/
27. (health adj5 educat*).tw.
28. (psychosocial or psycho-social).tw.
29. (cognitive adj2 behav*).tw.
30. or/1-29
31. exp heart transplantation/
32. (heart adj2 transplant*).tw.
33. (cardiac adj2 transplant*).tw.
34. heart graF*.tw.
35. or/31-34
36. 30 and 35
37. random$.tw.
38. factorial$.tw.
39. crossover$.tw.
40. cross over$.tw.
41. cross-over$.tw.
42. placebo$.tw.
43. (doubl$ adj blind$).tw.
44. (singl$ adj blind$).tw.
45. assign$.tw.
46. allocat$.tw.
47. volunteer$.tw.
48. crossover procedure/
49. double blind procedure/
50. randomized controlled trial/
51. single blind procedure/
52. 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51
53. (animal/ or nonhuman/) not human/
54. 52 not 53
55. 36 and 54
CINAHL
S55 S36 AND S54
S54 S37 or S38 or S39 or S40 or S41 or S42 or S43 or S44 or S45 or S46 or S47 or S48 or S49 or S50 or S51 or S52 or S53
S53 TX cross-over*
S52 TX crossover*
Exercise-based cardiac rehabilitation in heart transplant recipients (Protocol)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
14
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
S51 TX volunteer*
S50 (MH "Crossover Design")
S49 TX allocat*
S48 TX control*
S47 TX assign*
S46 TX placebo*
S45 (MH "Placebos")
S44 TX random*
S43 TX (doubl* N1 mask*)
S42 TX (singl* N1 mask*)
S41 TX (doubl* N1 blind*)
S40 TX (singl* N1 blind*)
S39 TX (clinic* N1 trial?)
S38 PT clinical trial
S37 (MH "Clinical Trials+")
S36 S30 AND S35
S35 S31 OR S32 OR S33 OR S34
S34 "heart graF*"
S33 cardiac N2 transplant*
S32 heart N2 transplant*
S31 (MH "Heart Transplantation+")
S30 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19
OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29
S29 (cognitive N2 behav*)
S28 (psychosocial or psycho-social)
S27 (health N5 educat*)
S26 (MH "Health Education")
S25 (motivat* N5 (intervention or interv*))
S24 psycho-educat* or psychoeducat*
S23 ((behavior* or behaviour*) N5 (modify or modificat* or therap* or change))
S22 counselling or counseling
S21 (MH "Counseling+")
S20 (psycholog* N5 intervent*)
S19 psychotherap*
S18 (MH "Psychotherapy+")
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Trusted evidence.
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S17 (self N5 (manag* or care or motivate*))
S16 (MH "Self Care+")
S15 ((lifestyle or life-style) N5 (interven* or program* or treatment*))
S14 patient* N5 educat*
S13 (MH "Dance Therapy")
S12 (("lifestyle" or life-style) N5 (physical* or activ*))
S11 (run* or walk* or jog* or danc*)
S10 kinesiotherap*
S9 (MH "Rehabilitation+")
S8 ((exercise* or fitness) N3 (treatment or intervent* or program*))
S7 (train* N5 (strength* or aerobic* or exercise*))
S6 physical* N5 (fit* or train* or therap* or activit*)
S5 rehabilitat*
S4 (MH "Exertion+")
S3 (MH "Physical Activity")
S2 (MH "Sports+")
S1 (MH "Therapeutic Exercise+")
Web of Science
# 8 #7 AND #6
# 7 TS=(random* or blind* or allocat* or assign* or trial* or placebo* or crossover* or cross-over*)
# 6 #5 AND #4
# 5 TS=("heart transplant*" or "cardiac transplant*" or "heart graF*")
# 4 #3 OR #2 OR #1
# 3 TS=(psychotherap* or psycholog* or counselling or counseling or behavior* or behaviour* or psycho-educat* or psychoeducat* or
motivat* or psychosocial or psycho-social or cognitive)
# 2 TS=("self manag*" or "self car*" or "self motivat*")
# 1 TS=(rehabilitat* or physical* or fit* or train* or exercise* or fitness or kinesiotherap* or run* or walk* or jog* or danc* or "lifestyle" or
life-style or sport*)
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